Wenyan Xu

机构：Tianjin Medical University · ORCID：0000-0002-8108-3463

发表论文 53 篇 · 总被引 890 次 · h-index 16

代表论文

• Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization (2023 · MedComm · 被引 28)
• Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways (2024 · The EMBO Journal · 被引 14)
• Differential Ire1 determines loser cell fate in tumor-suppressive cell competition (2023 · Cell Reports · 被引 14)
• Ptp61F integrates Hippo, TOR, and actomyosin pathways to control three-dimensional organ size (2022 · Cell Reports · 被引 12)
• L-tryptophan anaerobic fermentation for indole acetic acid production: Bacterial enrichment and effects of zero valent iron (2024 · Bioresource Technology · 被引 10)
• Inactivation of Invs/Nphp2 in renal epithelial cells drives infantile nephronophthisis like phenotypes in mouse (2023 · eLife · 被引 10)